We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Aug 2019
  • Code : CMI2975
  • Pages : 129
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

Market Dynamics

Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks.

Furthermore, monitoring of drugs including sucralfate in the U.S. by the government authorities for avoiding fatal conditions in the population is expected to drive the market growth. For instance, in 2017, the U.S. FDA updated name of 'Carafate suspension' to 'Carafate oral suspension' to avoid fatal complications with mistakenly intravenous administration of the drug.

Key features of the study:

  • This report provides in-depth analysis of the U.S. sucralfate market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the U.S. sucralfate market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The U.S. sucralfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. sucralfate market

Detailed Segmentation:

  • U.S. Sucralfate Market, By Formulation:
    • Tablet
    • Liquid Suspension
      • Unit Dose Cup
      • Bottle
  • U.S. Sucralfate Market, By Indication:
    • Gastric Ulcers
    • Duodenal Ulcers
    • Gastro Esophageal Reflux Disease (GERD)
    • Others
  • U.S. Sucralfate Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • U.S. Sucralfate Market, By State:
    • Illinois
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Texas
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • New York
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • California
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Others
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Allergan plc
    • Vertice Pharma LLC
    • Pharmaceutical Associates Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Formulation
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By State
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Market Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • Key Highlights
    • PEST Analysis
  4. U.S. Sucralfate Market, By Formulation, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Tablet
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Liquid Suspension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
        • Unit Dose Cup
        • Bottle
  5. U.S. Sucralfate Market, By Indication, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Gastric Ulcers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Duodenal Ulcers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Gastro Esophageal Reflux Disease (GERD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. U.S. Sucralfate Market , By Distribution Channel, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. U.S. Sucralfate Market , By State, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By State, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • Illinois
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Texas
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • New York
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • California
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Others
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Allergan plc
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vertice Pharma LLC
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pharmaceutical Associates Inc. (PAI)
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 17 figures on "Sucralfate Market - U.S. forecast to 2026”.

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo